Submitted by Anonymous (not verified) on 7 April 2026 - 12:48
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 9, Status: Authorised